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Introduction
Esophagectomy and mediastinal lymph node dissection 
are a principal treatment not only for early esophageal 
cancer, but also for locally advanced esophageal cancer 
as a vital component of multimodal therapy. However, 
esophagectomy for esophageal cancer is a high-risk 
surgical procedure, and in spite of the advancements in 
operative techniques and perioperative care approaches, 
esophagectomy can be associated with early postoperative 
mortality ranging from 1% to 13% of cases (1). Overall 
postoperative morbidity rates have been reported to be 
up to 50% (2), and 30-day readmission rates have been 
reported at 12% to 25%, which is higher than those for 
most other oncologic surgeries (3). These readmissions can 
increase unnecessary medical cost; in addition, readmission 
after esophagectomy for esophageal cancer has been 
reported to be related to poor survival regardless of initial 
stage and treatments (4).
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(ECCG) suggested that readmission to a primary or 
secondary hospital within 30 days of discharge after 
esophagectomy can be an important quality outcome 
indicator for esophagectomy (5). However, few research 
reports have analyzed the incidence of readmission 
after esophagectomy, particularly with a focus on risk 
factors that predispose patients with esophageal cancer 
to readmission after esophagectomy (3). To improve the 
quality of operative outcomes and patient care and to 
reduce unnecessary medical cost, esophageal surgeons must 
be aware of the incidence and risk factors of readmission 
after esophagectomy. Therefore, this retrospective study 
investigated the incidence and risk factors of readmission 
after elective esophagectomy for esophageal cancer based 
on data from a single institution. 
Methods
This retrospective study was approved by the institutional 
review board of our hospital (4-2018-0580). Records of 
291 patients who underwent elective esophagectomy 
with mediastinal and abdominal lymphadenectomy for 
esophageal cancer in the tertiary academic institution, from 
January 2006 to June 2017, were retrospectively reviewed. 
Salvage or palliative operation and operative mortality were 
used as exclusion criteria. The routine surgical procedures 
were McKeown esophagectomy; esophagectomy and total 
lymphadenectomy and cervical esophagogastrostomy. The 
minimally invasive approaches by robot or thoracoscopy 
were mainly applied in the thoracic phase, the laparotomy 
was usually done for the abdominal phase. The pyloric 
drainage procedures were not performed and jejunostomy 
tube was placed routinely. Even though we did not routinely 
apply the enhanced recovery after surgery (ERAS) program, 
the jejunostomy feeding was started at postoperative day 
(POD) 3 and the esophagography and vocal cord evaluation 
was done at POD 7 after operation. Sips of water and oral 
feeding were usually started at POD 7. The antithrombotic 
agents were not used at the immediate postoperative 
periods.
Patient factors, past medical history, and surgical and 
postoperative stay information were acquired from the 
institutional medical database system. Patient factors 
were age, sex, tumor location, histology, pathologic 
stage, and comorbidities. As a comorbidity, pulmonary 
disease was defined as the history of chronic obstructive 
pulmonary disease, pulmonary tuberculosis, emphysema, 
or bronchial asthma. Cardiac disease was defined as history 
of hypertension, coronary artery obstructive disease, 
valve disease, or arrhythmia. Postoperative factors were 
length of stay and postoperative complications. Pulmonary 
complications were defined as any pneumonic infiltrates 
on chest X-ray, acute lung injury, or adult respiratory 
distress syndrome (ARDS). Vocal cord examinations were 
routinely performed by an otolaryngologist to identify 
recurrent laryngeal nerve palsies. All patients underwent 
videostroboscopy to evaluate vocal fold motion and glottal 
configuration during inspiration and phonation at POD 7. 
Decreased vocal fold movement and fixed vocal folds 
were defined as vocal cord palsies. Esophagography was 
performed at POD 7 to rule out anastomotic leakage. 
Arrhythmia included all types of arrhythmias, such as atrial 
fibrillations or atrial flutters. Prolonged air leakage was 
defined as air leakage that was sustained beyond POD 7. 
All data were managed by the dedicated data manager (GE 
Byun). The severity of postoperative complications was 
graded by Clavien-Dindo classification (6). Readmission 
within 30 days after discharge was defined as inpatient 
admission to our institution within 30 days of discharge 
from a postoperative stay. The causes of readmission were 
analyzed based on the medical records. The costs generated 
during the readmission periods were calculated based on the 
institutional medical system and it defined as total cost for 
readmission. The final pathologic esophageal cancer stage 
was classified based on the 8th edition of the American Joint 
Committee on Cancer system of esophageal cancer (7). 
Statistical analysis
Statistical analysis was performed using the open source 
statistical software R (http://www.R-project.org). Clinical 
and pathological parameters were described as mean ± 
standard deviation for continuous variables and frequency 
(%) for categorical variables if the variables showed normal 
distribution. If variables did not show normal distribution, 
the parameters were described as median (inter-quantile 
range). Comparison of continuous variables was performed 
using Student’s t-test (2-sided). Logistic regression was used 
to identify risk factors associated with 30-day readmission. 
Variables identified as significant in univariable models 
(P<0.2) were included as covariates in the multivariable 
model. Odds ratios (ORs) and corresponding 95% 
confidence intervals (CIs) are reported. All tests were two-
sided, and the criterion for significance was P<0.05.
4702 Park et al. Readmission after esophagectomy
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2019;11(11):4700-4707 | http://dx.doi.org/10.21037/jtd.2019.10.34
Results
Patient demographics and postoperative complications 
Basic patient characteristics are described in Table 1. The 
mean patient age was 63.02±8.02 years, and 264 (90.7%) 
patients were male. Squamous cell carcinoma was identified 
as the majority of the pathologies (95.9%), and 14.1% of 
patients received neoadjuvant therapy.
The postoperative complications and outcomes are 
summarized in Table 2. These complications meant the 
complication which occurred during the first admission. 
In 134 patients showed postoperative complications. The 
highest grade based on the Clavien-Dindo classification was 
as follows; 19 in grade 1, 61 in grade 2, 31 in grade 3 and 23 
in grade 4, respectively. The most common complication 
was vocal cord palsy (21.3%). The mean hospital stay was 
25.61±27.42 days. The hospital stays were significantly 
higher in patients with postoperative complications than in 
patients without postoperative complications (16.0±6.10 vs. 
34.93±35.68 days, P<0.001). 
Incidence and reasons for readmission 
Thirty-nine (13.4%) patients were re-admitted within 
30 days after discharge. There were 24 (61.5%) among the 
39 patients readmitted within 2 weeks after initial discharge. 
The mean interval from initial discharge to readmission was 
13.46±9.36 days. Causes for readmission are summarized in 
Table 3. Common causes of readmission were anastomotic 
stricture requiring ballooning (12, 30.7%), wound problem 
Table 1 Patient characteristics (n=291)
Variables Value
Age (years) 63.02±8.02
Male 264 (90.7)
Smoking history (pack-year) 33.76±18.27
FEV1 (%) 99.90±18.27
FVC (%) 97.81±17.87
Charlson Comorbidity Index 
0 93 (32.0)
1 97 (33.3)
2 53 (18.2)
3 38 (13.1)
4 10 (3.4)
Cardiac disease 82 (28.2)
Diabetes mellitus 34 (11.7)
Pulmonary disease 52 (17.9)
Pathology
Squamous cell carcinoma 279 (95.9)
Adenocarcinoma 12 (4.1)
Location
Upper 24 (8.2)
Mid 157 (54.0)
Lower 110 (37.8)
Pathologic stage
0 21 (7.2)
I 112 (38.5)
II 71 (24.4)
III 74 (25.4)
IV 13 (4.5)
Neoadjuvant therapy 41 (14.1)
The data were described as mean ± standard deviation for 
continuous variables and frequency (%). FEV1, forced expiratory 
volume in the first second; FVC, forced vital capacity.
Table 2 Postoperative outcomes (n=291)
Variables Value
Postoperative complications, n (%)
Vocal cord palsy 62 (21.3)
Pulmonary complications 35 (12.0)
Anastomotic leakage 30 (10.3)
Chyloperitoneum 2 (0.7)
Chylothorax 3 (1.0)
Wound problem 3 (1.0)
Postoperative bleeding 2 (0.7)
Prolonged air leakage 1 (0.3)
Pleural effusion 10 (3.43)
Acute renal failure 3 (1.0)
Arrhythmia 7 (2.4)
Intensive care unit stay (days), median [IQR] 1 [1–3]
Hospital stay (days), median [IQR] 17 [14–26]
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(7, 17.9%), pneumonia (6, 15.4%), and poor oral intake (4, 
10.2%). Other causes of readmission were delayed gastric 
emptying [3], jejunostomy tube problem [2], ileus [2], 
pain [1], pneumothorax [1], and pleural effusion [1]. Among 
the 7 patients with wound problems, 4 showed neck wound 
problems, and the other 3 patients had wound problems at 
the chest tube site or abdomen. The mean hospital stay for 
readmission was 11.41±10.92 days (range, 1–38 days). The 
mean total cost for readmission was 4,386,278±4,492,302 
Korean won (approximately $4,041 US dollars). 
Risk factors of readmission 
On univariable analysis, history of pulmonary disease 
(OR =2.132, 95% CI: 1.159–3.920, P=0.015), vocal cord 
palsy (OR =2.758, 95% CI: 1.554–4.896, P=0.001), and 
anastomotic leakage (OR =2.247, 95% CI: 1.049–4.813, 
P=0.037) were primary risk factors of readmission after 
esophagectomy. Frequency of hospital stay was significantly 
higher in patients with postoperative complications 
than in patients without postoperative complications 
(P<0.001); the length of hospital stay was not included 
in multivariable analysis. On multivariable analysis, only 
postoperative anastomotic leakage was identified as a risk 
factor of readmission after esophagectomy (OR =2.884, 
95% CI: 1.133–7.343, P=0.026), whereas vocal cord palsy 
and pathologic stages were not related to readmission. In 
30 patients with postoperative anastomotic leakage, the 
frequency of readmission due to wound problem (13.3% vs. 
1.1%, P=0.003) or anastomotic stricture (13.3% vs. 3.4%, 
P=0.034) was significantly higher than patients without 
anastomotic leakage (Table 4).
Discussion
Our data showed that the rate of readmission within 30 days 
after esophagectomy was 13.4% and was primarily 
related to postoperative anastomotic leakage and wound 
problem. Readmission resulted in additional hospital 
cost of 4,386,278±4,492,302 Korean won (approximately 
$4,041 US dollars). The readmission rate and risk factors 
reported in previous studies are summarized in Table 5. 
Previous studies showed similar incidence of readmission 
after esophagectomy to our results, about 12.6–25% 
(1,4). Previous studies have proposed possible risk factors 
for readmission, including postoperative complications, 
Table 3 Characteristics and causes of readmission (n=39)
Characteristics Value
Mean time from initial discharge to readmission (days) 13.46±9.36
Length of stay during readmission (days), median [IQR] 8 [3–16]
Total cost for readmission (Korean Wons), median [IQR] 2,619,812 [1,075,895–6,269,485]
Cause of readmission, n (%)
Anastomotic stricture requiring ballooning dilatation 12 (30.7)
Wound problem 7 (17.9)
Pneumonia 6 (15.4)
Poor oral intake 4 (10.2)
Delayed gastric emptying 3 (7.7)
Jejunostomy tube problem 2 (5.1)
Ileus 2 (5.1)
Pain 1 (2.6)
Pneumothorax 1 (2.6)
Pleural effusion requiring closed drainage 1 (2.6)
Numbers of patients who required the procedure during readmission 15 (38.4)
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Table 4 Risk factors of readmission after esophagectomy 
Variables
Univariable analysis Multivariable analysis
Odds ratio (95% CI) P Odds ratio (95% CI) P
Sex 1.660 (0.667–4.067) 0.268 – –
Age 1.004 (0.975–1.034) 0.797 – –
Charlson comorbidity index
1–2 (vs. 0) 1.351 (0.658–2.773) 0.412 – –
3–4 (vs. 0) 1.420 (0.559–3.607) 0.461 – –
Neoadjuvant therapy 0.666 (0.324–1.369) 0.269 – –
Pathologic stage
I (vs. 0) 1.219 (0.413–3.603) 0.072 1.855 (0.378–9.095) 0.446
II (vs. 0) 2.071 (0.692–6.192) 0.193 1.752 (0.349–8.801) 0.496
III and IV (vs. 0) 3.109 (1.025–9.428) 0.045 0.630 (0.107–3.710) 0.610
Cardiac disease 1.870 (1.106–3.161) 0.019 1.597 (0.766–3.330) 0.212
Diabetes mellitus 1.061 (0.507–2.221) 0.875 – –
Pulmonary disease 2.132 (1.159–3.920) 0.015 1.708 (0.753–3.877) 0.200
Postoperative complications
Vocal cord palsy 2.758 (1.554–4.896) 0.001 1.241 (0.560–2.749) 0.596
Pulmonary complications 0.930 (0.442–1.956) 0.848 – –
Anastomotic leakage 2.247 (1.049–4.813) 0.037 2.884 (1.133–7.343) 0.026
Table 5 Summary of the literature on readmission after esophagectomy 
Author
Publication 
year
Number of 
patients
Patient characteristics
30-day readmission 
rate (%)
Risk factors of readmission
Fernandex et al. (4) 2015 1,744 SEER database  
(2002–2009)
18.6 Comorbidity score of 3+
Urgent admission
Urban residence
Shah et al. (3) 2015 306 Single institute (1993–2011) 13.7 Postoperative complications
Sundaram et al. (8) 2015 1,068 National Surgical Quality 
Improvement Program 
dataset (2011–2012)
12.6 History of pulmonary disease
Postoperative wound 
complications
Length of stay
Hu et al. (1) 2015 1,543 SEER-Medicare registry 
(2000–2009)
20.7 Induction chemotherapy
This study 2018 291 Single institute (2006–2017) 13.4 Postoperative anastomotic 
leakage
SEER, Surveillance, Epidemiology, and End Results Program.
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thromboembolic events, pulmonary complications, wound 
problems, and longer hospital stay (3,4,8). The initial 
hospital stay was not included in this risk factor analysis 
because we thought that prolonged hospital stay reflects 
the postoperative complications. A hospital stay is naturally 
prolonged if postoperative complications occur. Shah et al. 
reported that postoperative complications were related to 
readmission after esophagectomy, and that complications 
that were not adequately managed before discharge 
could lead to readmission (3). They reported that the 
incidence of postoperative complications was 48%, but 
the study did not analyze detailed types of postoperative 
complications. Various kinds of complications can occur 
after esophagectomy, and the incidence of complications has 
been reported up to 50% (9). We hypothesized that specific 
but not all complications might be related to readmission. 
Our initial hypothesis was that postoperative vocal 
cord palsy can cause swallowing difficulties, aspiration 
pneumonia, and related readmission. Our group has an 
aggressive surgical policy for mediastinal lymphadenectomy, 
which can be associated with postoperative vocal cord palsy, 
in approximately 20% of cases. Postoperative vocal cord 
palsy can cause swallowing difficulties, poor oral intake, 
and poor quality of life during the follow-up period (10). 
Baba et al. reported that patients with severe hoarseness 
and permanent recurrent nerve paralysis showed poor food 
intake at 24 months or less postoperatively and restricted 
daily activity and difficulty in talking at 60 months or 
more after the operation (10). In addition, several papers 
reported that recurrent laryngeal nerve palsy is related to 
postoperative pulmonary complications due to recurrent 
laryngeal nerve palsy-related aspiration (11). Therefore, 
we hypothesized that recurrent laryngeal nerve palsy-
related aspiration could affect the postoperative course after 
discharge and result in readmission. In contrast to our initial 
hypothesis, the data showed that postoperative vocal cord 
palsy was not related to readmission after esophagectomy. 
This result might be related to the intensive patient 
education after operation. We administered an education 
program on postoperative care after esophagectomy, which 
specifically focused on diet and ways to eat food in patients 
with vocal cord palsy and difficulty swallowing.
In contrast to the initial hypothesis, postoperative 
anastomotic leakage was found to be related to readmission. 
Twelve (30.7%) patients required endoscopic ballooning 
due to the anastomotic stricture which might be related 
to the postoperative anastomotic leakage, and 4 among 
the 7 patients with wound problems had problems with 
neck wounds. Neck wound problems could be related to 
subclinical minor anastomotic leakage. Therefore, the 16 
(41%) patients that experienced this could have associated 
anastomotic problems. The incidence of anastomotic 
leakage after initial operation in this study was 10.3%, which 
was comparable and slightly lower than previous reports, 
especially the results of the Japan Nationwide database 
(rate of anastomotic leakage; 13.3%) (9). Our incidence 
of anastomotic leakage was acceptable, but the incidence 
of anastomotic leakage should be decreased to reduce 
readmission rates. Therefore, risk factors of anastomotic 
leakage identified in our series will be analyzed in further 
studies. Based on these results, technical modification for 
anastomosis and conduit preparation and improvement of 
perioperative management should also be studied. 
Even though the incidence was low, there were several 
readmissions related to jejunostomy. We placed the 
jejunostomy tube for proper nutritional support during the 
perioperative period. This approach was used particularly 
when patients are expected to vocal cord palsy due to 
aggressive mediastinal lymph node dissection; therefore, 
enteral nutritional support instead of oral intake could 
be helpful. In some cases, the jejunostomy tube can cause 
complications, such as intestinal obstruction; in our 
series, two patients suffered from mechanical obstruction 
attributable to the jejunostomy tube. Therefore, alternative 
routes for postoperative nutrition instead of jejunostomy 
and surgical technique modifications to reduce jejunostomy-
related complications should be studied further. Ninomiya 
et al. suggested that inserting the catheter for gastrostomy 
through a gastric conduit could prevent jejunostomy-related 
bowel obstruction (12).
In previous  s tudies ,  venous thromboembolism 
was a main reason for readmission, and prophylaxis 
for venous thromboembolism was recommended (3). 
However, the results of this study did not indicate any 
thrombosis-related readmission. A systematic review 
of the incidence of venous thromboembolism in Asian 
patients indicated that population-wide incidence estimates 
in Asia were approximately 15% to 20% of the levels 
recorded in Western countries (13). In addition, venous 
thromboembolism is rarely reported during immediate 
postoperative periods for initial esophagectomy. It is 
possible that the low incidence of postoperative thrombotic 
events in our patients could be related to ethnic differences 
and differences between Western and Eastern patients. 
Therefore, the cause of readmission after esophagectomy 
could different depending on race, region, and country. 
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Based on this, postoperative care and plans to reduce 
readmission rates should be individualized based on race 
and geographical region. 
There were several limitations to this study. First, this 
study analyzed patients from a single institution over 
10 years and the pathologies were mainly esophageal 
squamous cell carcinoma. Therefore, the results have to 
be interpreted cautiously because each institution and 
surgeons have different surgical polices, and frequent 
complications could differ. In addition, similar to rates of 
venous thromboembolism, there were racial differences. 
However, these results reflect cases that were treated at our 
institution and can provide guidance for improvements in 
patient treatment and procedural approaches. Based on the 
results, consideration of complications and readmission should 
be individualized to optimize patient outcomes. Second, 
due to the characteristics of the National Health Insurance 
of Korea, the rate of readmission might be overestimated. 
Specifically, the 4 (10.2%) patients that were readmitted due 
to poor oral intake could be related to the he characteristics 
of the National Health Insurance. In the National Health 
Insurance of Korea system, the patients pay only about 
10 US dollars for hospitalization per day, which is relatively 
inexpensive compared to other countries, especially the United 
States. Due to the low hospitalization costs, patients expect and 
demand hospitalization even for mild symptoms that can be 
managed in outpatient clinics. Finally, within the same context, 
the economic burden due to readmission referred to in this 
paper might be smaller than in other countries.
In conclusion, the rate of readmission within 30 days 
after esophagectomy was 13.4% in our data and was 
primarily related to postoperative anastomotic leakage 
and wound problems. Based on the results, technical 
improvements to reduce anastomotic leakage and wound 
problems are necessary to improve esophagectomy surgical 
quality and patient outcomes.
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